Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease
about
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.New developments in the medical management of prostate cancer.Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not -A or -C, in male smokers.Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis.Thrombin expression in prostate: a novel finding.PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.Modulating metastasis by a lymphangiogenic switch in prostate cancer.An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer.Association of the serum vascular endothelial growth factor levels with benign prostate hyperplasia and prostate malignancies.
P2860
Q33509896-DEEAE548-C4C5-419F-ACAD-570958A45867Q33566738-4B992156-62F2-4443-9BE5-1296C713D0BEQ35335324-226620D7-82D1-439A-98CC-0D2352AC226CQ36130890-D93AFFA0-B218-4736-9CE2-54E89D5A7906Q36202911-D75FB7FF-F97F-48D3-90B8-D838D5915BB3Q36545778-D4D020D2-9C09-4F7C-BE19-09027DF0F30AQ36611325-A6212702-E0E6-4236-A936-F49705ADAE61Q36612618-9211753B-441D-4E4E-B146-068BE1B28C91Q37156639-E8CE798A-80D8-4DC4-A970-36095C9B2C1FQ37366248-96B02764-03D1-4138-A696-83EDF21F3C2DQ38413090-A11A7642-1D28-4335-BE3C-130698C31CE4Q39357182-325339A4-94C5-4A49-B283-405715DF502EQ39618556-2FF07A28-B1EC-4295-B025-6353092CC9F1Q41862411-296B3822-31FB-4654-AD96-562DA92D4FECQ42159112-1672CE04-28BF-4314-BFD8-EA0476D8D02B
P2860
Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stage-specific characterizatio ...... ed with advanced-stage disease
@ast
Stage-specific characterizatio ...... ed with advanced-stage disease
@en
Stage-specific characterizatio ...... ed with advanced-stage disease
@nl
type
label
Stage-specific characterizatio ...... ed with advanced-stage disease
@ast
Stage-specific characterizatio ...... ed with advanced-stage disease
@en
Stage-specific characterizatio ...... ed with advanced-stage disease
@nl
prefLabel
Stage-specific characterizatio ...... ed with advanced-stage disease
@ast
Stage-specific characterizatio ...... ed with advanced-stage disease
@en
Stage-specific characterizatio ...... ed with advanced-stage disease
@nl
P2093
P1476
Stage-specific characterizatio ...... ed with advanced-stage disease
@en
P2093
Donald E Johnson
Eric R Siegel
Manish Kohli
Perkins Mukunyadzi
Richard A Dennis
Varsha Kaushal
P304
P407
P433
P577
2005-01-15T00:00:00Z